| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.981 | 37.652 | 49.207 | 44.817 | 53.593 | 56.721 | 62.215 | 73.896 | 77.414 |
| Total Income - EUR | - | 14.981 | 37.653 | 49.208 | 44.818 | 53.593 | 57.865 | 61.069 | 73.898 | 77.416 |
| Total Expenses - EUR | - | 8.379 | 12.678 | 20.106 | 22.246 | 21.801 | 19.882 | 22.177 | 36.791 | 42.915 |
| Gross Profit/Loss - EUR | - | 6.602 | 24.974 | 29.102 | 22.572 | 31.792 | 37.983 | 38.892 | 37.107 | 34.501 |
| Net Profit/Loss - EUR | - | 6.452 | 24.598 | 28.610 | 22.123 | 31.287 | 37.404 | 38.294 | 36.383 | 32.224 |
| Employees | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Cp Medifem S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 3.863 | 3.297 | 11.057 | 9.233 | 7.450 | 5.890 | 4.294 | 2.700 |
| Current Assets | - | 7.027 | 21.356 | 26.373 | 12.243 | 23.222 | 31.149 | 49.136 | 35.133 | 32.970 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.861 | 17.288 | 23.047 | 10.658 | 14.403 | 19.954 | 38.269 | 30.921 | 20.113 |
| Cash | - | 4.166 | 4.068 | 3.326 | 1.585 | 8.819 | 11.195 | 10.866 | 4.211 | 12.857 |
| Shareholders Funds | - | 6.496 | 24.650 | 28.662 | 22.174 | 31.337 | 37.453 | 38.342 | 36.432 | 32.273 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 531 | 569 | 1.008 | 1.126 | 1.118 | 1.146 | 16.684 | 2.995 | 3.397 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cp Medifem S.r.l.